Work

Neoadjuvant enzalutamide (ENZA) and abiraterone acetate (AA) plus leuprolide acetate (LHRHa) versus AA+ LHRHa in localized high-risk prostate cancer (LHRPC).

Year: 2016

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2016.34.15_suppl.5002

Authors: Eleni Efstathiou, John W. Davis, Mark Anton Titus, Brian Francis Chapin, Amado J. Zurita, Sijin Wen, Elsa M. Li Ning Tapia, Anh Hoang, Paul Gettys Corn, Xuemei Wang, Francine Whittington, Patricia Troncoso, Christopher Logothetis

Institutions: National and Kapodistrian University of Athens, Alexandra Hospital, The University of Texas MD Anderson Cancer Center, West Virginia University

Language: English

Topic: Prostate Cancer Treatment and Research

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2743126402

Cites:

Cited by: 12

Related to: 10